Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 263 blog entries.

8 products added to the Discount Not Deducted (DND) list from August 2025

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 8 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 August 2025. This takes the total [...]

The post 8 products added to the Discount Not Deducted (DND) list from August 2025 appeared first on Community Pharmacy England.

By |July 29th, 2025|Lexpos News|Comments Off on 8 products added to the Discount Not Deducted (DND) list from August 2025

NHSBSA ‘Hints & Tips’ – Issue 60

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 60) contains some useful information and advice on: CPAF screening questionnaire closes Thursday 31 July 2025 NHS Pharmacy First Service: fixed payment arrangement and capping changes NHS Pharmacy First Service: claim window changes Help [...]

The post NHSBSA ‘Hints & Tips’ – Issue 60 appeared first on Community Pharmacy England.

By |July 28th, 2025|Lexpos News|Comments Off on NHSBSA ‘Hints & Tips’ – Issue 60

Expiry of SSP083 Venlafaxine 37.5mg modified-release tablets

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Venlafaxine 37.5mg modified-release tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP083 Venlafaxine 37.5mg modified-release tablets expires at 23.59pm on Tuesday 22nd July 2025. After this date, any prescriptions for Venlafaxine 37.5mg modified-release [...]

The post Expiry of SSP083 Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

By |July 22nd, 2025|Lexpos News|Comments Off on Expiry of SSP083 Venlafaxine 37.5mg modified-release tablets

National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets – Updated

Update: 11 July 2025 DHSC have provided an update that Bumetanide 1mg tablets are in limited supply until late July 2025 National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets National Patient Safety Alert Reference Number: NatPSA/2025/003/DHSC Date issued: 03 July 2025 Explanation of identified safety issue Bumetanide 1mg tablets are out of stock until [...]

The post National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets – Updated appeared first on Community Pharmacy England.

By |July 3rd, 2025|Lexpos News|Comments Off on National Patient Safety Alert: Shortage Of Bumetanide 1mg Tablets – Updated

MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd)

MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) Drug Alert Number: EL(25)A/31 Date issued: 30 June 2025 Wockhardt UK Limited is recalling the above batch as a precautionary measure following the identification of a dissolution failure during stability testing. DMRC reference number:DMRC-35980389 Marketing Authorisation Holder:Wockhardt UK Ltd Medicine Details Product name: Tamoxifen 20mg [...]

The post MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) appeared first on Community Pharmacy England.

By |June 30th, 2025|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd)